Acceleron Pharma (NASDAQ:XLRN)

CAPS Rating: 5 out of 5

XLRN News and Commentary

Caps

How do you think XLRN will perform against the market?

Add Stock to CAPS Watchlist

All Players

33 Outperform
1 Underperform
 

All-Star Players

12 Outperform
0 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top XLRN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFSpiffyPop (99.86)
Submitted June 29, 2015

Bit of a flyer, but I like orphan-drug companies and in this case the partner is Celgene, a company I greatly esteem. Outperform.

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

XLRN VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about XLRN.

Recs

0
Member Avatar Bigsef77 (70.16) Submitted: 6/29/2018 10:14:54 AM : Outperform Start Price: $28.56 XLRN Score: +44.11

Celgene and Acceleron Announce Luspatercept Achieved Primary and Key Secondary Endpoints in Phase III ‘MEDALIST’ Study in Patients with Low-to-Intermediate Risk Myelodysplastic Syndromes

Recs

0
Member Avatar adamicius (< 20) Submitted: 3/17/2017 11:48:23 AM : Outperform Start Price: $27.96 XLRN Score: +46.69

Another Celgene partnership play. Lead therapeutic candidate, luspatercept, is being evaluated in Phase 3 studies for the treatment of the hematologic diseases, myelodysplastic syndromes (MDS) and beta-thalassemia under a global partnership with Celgene Corp.

Recs

0
Member Avatar mdriver78 (67.36) Submitted: 7/27/2015 9:04:17 AM : Outperform Start Price: $28.59 XLRN Score: +25.71

SpiffyPop

Leaderboard

Find the members with the highest scoring picks in XLRN.

Score Leader

DoubleBagel

DoubleBagel (47.11) Score: +83.63

The Score Leader is the player with the highest score across all their picks in XLRN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
DoubleBagel 47.11 1/23/2017 Outperform 5Y $24.24 +89.60% +23.71% +65.89 0 Comment
K28hill < 20 9/24/2013 Outperform 5Y $20.78 +121.17% +64.01% +57.17 0 Comment
Reallynow222 97.26 2/22/2017 Outperform 5Y $26.41 +74.02% +18.35% +55.67 0 Comment
adamicius < 20 3/17/2017 Outperform 5Y $27.96 +64.38% +17.69% +46.69 1 Comment
Bigsef77 70.16 5/11/2017 5/22/2018 Outperform 3Y $28.56 +60.92% +16.81% +44.11 1 Comment
stockpickeraz 27.47 9/25/2013 Outperform 3W $22.20 +107.03% +65.07% +41.96 0 Comment
Hoofer38 49.98 10/23/2013 Outperform 5Y $23.33 +97.00% +60.08% +36.92 0 Comment
ReaperKK < 20 9/3/2014 Outperform 3Y $26.58 +72.91% +38.71% +34.20 1 Comment
mdriver78 67.36 7/27/2015 Outperform 5Y $28.59 +60.76% +35.04% +25.71 1 Comment
sikiliza < 20 4/24/2018 Outperform 5Y $36.02 +27.60% +4.34% +23.26 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackPiperJaff 87.65 10/14/2013 Outperform NS $22.48 +104.45% +65.08% +39.36 0 Comment

Featured Broker Partners


Advertisement